nitroglycerin has been researched along with Anxiety in 10 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
Excerpt | Relevance | Reference |
---|---|---|
" The aim of this study was to analyze the sensitivity of rats with prenatal hyperhomocysteinemia (hHCY) in respect of the development of behavioral correlates of headache and spreading cortical depolarization (CSD) in a migraine model induced by the administration of the nitric oxide (NO) donor nitroglycerin." | 8.12 | Hyperhomocysteinemia Increases Cortical Excitability and Aggravates Mechanical Hyperalgesia and Anxiety in a Nitroglycerine-Induced Migraine Model in Rats. ( Bogatova, K; Enikeev, D; Gerasimova, E; Giniatullin, R; Hermann, A; Sitdikova, G; Yakovleva, O, 2022) |
"Chronic migraine is a debilitating disorder that has a significant impact on patients and society." | 5.46 | Chronic ghrelin treatment reduced photophobia and anxiety-like behaviors in nitroglycerin- induced migraine: role of pituitary adenylate cyclase-activating polypeptide. ( Alipour, MR; Babri, S; Bughchechi, R; Farajdokht, F; Karimi, P; Mohaddes, G, 2017) |
" The aim of this study was to analyze the sensitivity of rats with prenatal hyperhomocysteinemia (hHCY) in respect of the development of behavioral correlates of headache and spreading cortical depolarization (CSD) in a migraine model induced by the administration of the nitric oxide (NO) donor nitroglycerin." | 4.12 | Hyperhomocysteinemia Increases Cortical Excitability and Aggravates Mechanical Hyperalgesia and Anxiety in a Nitroglycerine-Induced Migraine Model in Rats. ( Bogatova, K; Enikeev, D; Gerasimova, E; Giniatullin, R; Hermann, A; Sitdikova, G; Yakovleva, O, 2022) |
"Systemic administration of nitroglycerin (NTG) consistently provokes spontaneous-like migraine attacks in migraine sufferers, and in rat it induces hyperalgesia and allodynia." | 3.83 | Ghrelin attenuates hyperalgesia and light aversion-induced by nitroglycerin in male rats. ( Babri, S; Farajdokht, F; Karimi, P; Mohaddes, G, 2016) |
"Pretreatment with PL ameliorated migraine headache behaviors in the NTG-induced migraine rat model, suggesting pretreatment with PL is beneficial for migraine headache treatment." | 1.51 | Effect of Paeonia lactiflora, a traditional Chinese herb, on migraines based on clinical application and animal behavior analyses. ( Chen, CH; Hsieh, CL; Li, JM; Liao, CC; Lin, CL, 2019) |
"Chronic migraine is a debilitating disorder that has a significant impact on patients and society." | 1.46 | Chronic ghrelin treatment reduced photophobia and anxiety-like behaviors in nitroglycerin- induced migraine: role of pituitary adenylate cyclase-activating polypeptide. ( Alipour, MR; Babri, S; Bughchechi, R; Farajdokht, F; Karimi, P; Mohaddes, G, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (50.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Gerasimova, E | 1 |
Yakovleva, O | 1 |
Enikeev, D | 1 |
Bogatova, K | 1 |
Hermann, A | 1 |
Giniatullin, R | 1 |
Sitdikova, G | 1 |
Liao, CC | 1 |
Li, JM | 1 |
Chen, CH | 1 |
Lin, CL | 1 |
Hsieh, CL | 1 |
Farajdokht, F | 2 |
Babri, S | 2 |
Karimi, P | 2 |
Mohaddes, G | 2 |
Alipour, MR | 1 |
Bughchechi, R | 1 |
PAUL, O | 1 |
SHAPIRO, S | 1 |
Wheatley, D | 1 |
Jones, DA | 1 |
West, RR | 1 |
Piris, P | 1 |
Beaughard, M | 1 |
Cosnier, D | 1 |
Labrid, C | 1 |
Goia, F | 1 |
Tesi, U | 1 |
Carezzana, G | 1 |
Schettino, F | 1 |
Silvestri, G | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Enhancing Standard Cardiac Rehabilitation With Stress Management Training in Patients With Heart Disease[NCT00981253] | 164 participants (Actual) | Interventional | 2009-09-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
A global stress measure (mean rank), was the primary outcome combining the following components at baseline and following treatment: Beck Depression Inventory II, Spielberger Anxiety Inventory-State, General Health Questionnaire, PROMIS Anger Questionnaire, and Perceived Stress Scale. A range from 1 to 147 was present with higher scores suggestive of better function. The change in each individual scaled score is presented in primary outcome 2. (NCT00981253)
Timeframe: Baseline; 12 weeks
Intervention | Mean rank score (Least Squares Mean) |
---|---|
SMT-enhanced Cardiac Rehabilitation | 77.6 |
Standard Cardiac Rehabilitation | 67.5 |
Baroreflex sensitivity was obtained from beat-to-beat heart rate and blood pressure recorded from patients in the supine position with a Nexfin noninvasive blood pressure monitor. (NCT00981253)
Timeframe: At 12 weeks
Intervention | ms/mm Hg (Least Squares Mean) |
---|---|
SMT-Enhanced Cardiac Rehabilitation | 0.47 |
Standard Cardiac Rehabilitation | 0.93 |
High-sensitivity C-reactive protein was quantified by ELISA. Values >10 mg/L were truncated at 10 to account for acute inflammatory processes that may have skewed the distribution of this blood marker. (NCT00981253)
Timeframe: Baseline; 12 weeks
Intervention | mg/L (Least Squares Mean) |
---|---|
SMT-enhanced Cardiac Rehabilitation | -0.9 |
Standard Cardiac Rehabilitation | -0.4 |
Heart rate variability was obtained from beat-to-beat heart rate. Heart rate was assessed from R-R interval changes elicited during a 100-second controlled breathing task. (NCT00981253)
Timeframe: At 12 weeks
Intervention | ms (Least Squares Mean) |
---|---|
SMT-Enhanced Cardiac Rehabilitation | 13.1 |
Standard Cardiac Rehabilitation | 26.0 |
"Beck Depression Inventory II: 21-item scale used to measure depression. Scores range from 0 to 63, with higher scores suggesting greater depressive symptoms.~State-Trait Anxiety Inventory: 20-item scale which assess levels of state anxiety. Scores range from 20 to 80 with scores ≥40 suggesting clinically significant anxiety.~General Health Questionnaire:12-item measure of general distress. Scores range from 0 to 36, with higher scores indicating greater emotional distress.~Patient-Reported Outcomes Measurement Information System (PROMIS) Anger: 8-item scale which assesses anger. Scores range from 8 to 40, with higher scores indicating greater anger.~Perceived Stress Scale: 10-item measure of general distress and perceived ability to cope. Scores range from 0 to 40, higher scores indicate greater stress." (NCT00981253)
Timeframe: Baseline; 12 weeks
Intervention | units on a scale (Least Squares Mean) | ||||
---|---|---|---|---|---|
Beck Depression Inventory-II | Spielberger Anxiety Inventory-State | General Health Questionnaire | PROMIS Anger Questionnaire | Perceived Stress Score | |
SMT-Enhanced Cardiac Rehabilitation | -3.5 | -5.6 | -4.8 | -2.0 | -4.2 |
Standard Cardiac Rehabilitation | -2.6 | -2.6 | -3.3 | -1.0 | -2.6 |
Heart rate variability was obtained from beat-to-beat heart rate. Heart rate was assessed from R-R interval changes elicited during 5 minutes of normal relaxed breathing (NCT00981253)
Timeframe: At 12 weeks
Intervention | ln (ms^2) (Least Squares Mean) | |
---|---|---|
Low-frequency | High-frequency | |
SMT-Enhanced Cardiac Rehabilitation | 0.17 | 0.08 |
Standard Cardiac Rehabilitation | 0.28 | 0.22 |
Patients documented all medical encounters on an annual basis after enrollment. Medical records were reviewed, and events, categorized on the basis of American College of Cardiology/American Heart Association criteria. The following medical events were included: all-cause mortality, fatal and nonfatal myocardial infarction (MI), coronary or peripheral artery revascularization, stroke/transient ischemic attack, and unstable angina requiring hospitalization. (NCT00981253)
Timeframe: Baseline through Follow-up (median, 3.2 years)
Intervention | Participants (Count of Participants) | |||||
---|---|---|---|---|---|---|
All cause mortality | MI | Stent/CABG | Stroke/TIA | Peripheral Revascularization | Angina Requiring Hospitalization | |
SMT-enhanced Cardiac Rehabilitation | 0 | 1 | 9 | 1 | 1 | 2 |
Standard Cardiac Rehabilitation | 2 | 6 | 11 | 1 | 3 | 2 |
1 trial available for nitroglycerin and Anxiety
Article | Year |
---|---|
Psychological rehabilitation after myocardial infarction: multicentre randomised controlled trial.
Topics: Angina Pectoris; Anxiety; Depression; Follow-Up Studies; Humans; Myocardial Infarction; Nitroglyceri | 1996 |
9 other studies available for nitroglycerin and Anxiety
Article | Year |
---|---|
Hyperhomocysteinemia Increases Cortical Excitability and Aggravates Mechanical Hyperalgesia and Anxiety in a Nitroglycerine-Induced Migraine Model in Rats.
Topics: Animals; Anxiety; Cortical Excitability; Female; Homocysteine; Hyperalgesia; Hyperhomocysteinemia; M | 2022 |
Effect of Paeonia lactiflora, a traditional Chinese herb, on migraines based on clinical application and animal behavior analyses.
Topics: Animals; Anxiety; Behavior, Animal; Calcitonin Gene-Related Peptide; Depression; Drugs, Chinese Herb | 2019 |
Ghrelin attenuates hyperalgesia and light aversion-induced by nitroglycerin in male rats.
Topics: Animals; Anxiety; Disease Models, Animal; Ghrelin; Hyperalgesia; Male; Migraine Disorders; Nitroglyc | 2016 |
Chronic ghrelin treatment reduced photophobia and anxiety-like behaviors in nitroglycerin- induced migraine: role of pituitary adenylate cyclase-activating polypeptide.
Topics: Animals; Anxiety; Ghrelin; Hydrocortisone; Leukocyte Count; Male; Maze Learning; Migraine Disorders; | 2017 |
INTRACTABLE ANGINA.
Topics: Anemia; Angina Pectoris; Anticoagulants; Anxiety; Cardiac Surgical Procedures; Cardiovascular Diseas | 1963 |
ANGINA PECTORIS--AN EFFECTIVE THERAPEUTIC APPROACH.
Topics: Angina Pectoris; Anxiety; Anxiety Disorders; Humans; Meprobamate; Nitroglycerin; Pentaerythritol Tet | 1963 |
Coronary heart disease: treating the anxiety component.
Topics: Angina Pectoris; Anti-Anxiety Agents; Anxiety; Blood Pressure; Clorazepate Dipotassium; Coronary Dis | 1980 |
Activity of bepridil and other anti-anginals on cardiovascular modifications engendered by conditioned anxiety in the dog.
Topics: Amines; Amiodarone; Angina Pectoris; Animals; Anxiety; Behavior, Animal; Benzylamines; Conditioning, | 1978 |
[Prevention and therapy of angina pectoris and their relationship to dental practice].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anxiety; Calcium Channel Blockers; Dental Care; Humans | 1986 |